Evidence map›Paper›PMID 28229915›Full record

ReviewFree radical biology & medicine2017

Regulated methionine oxidation by monooxygenases.

Bruno Manta, Vadim N Gladyshev

Open access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Formylation facilitates the reduction of oxidized initiator methionines.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Parallel actin monomers in the 8S complex of actin-INF2.Journal of biomolecular structure & dynamics · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Journal of biomolecular NMR · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bruno MantaBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Vadim N GladyshevBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: vgladyshev@rics.bwh.harvard.edu.
Harvard University · US

Funding

Methionine sulfoxide reduction, selenium and agingR01AG021518 · NIA · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2003 to 2018
$5.0M
IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
STRUCTURE/FUNCTION OF CONNECTIVE TISSUE GROWTH FACTORR01GM065603 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GROTENDORST, GARY R · 2001 to 2004
$1.4M
NIA NIH HHS R01 AG021518NIGMS NIH HHS R01 GM061603NIGMS NIH HHS R01 GM065603NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

Protein function can be regulated via post-translational modifications by numerous enzymatic and non-enzymatic mechanisms, including oxidation of cysteine and methionine residues. Redox-dependent regulatory mechanisms have been identified for nearly every cellular process, but the major paradigm has been that cellular components are oxidized (damaged) by reactive oxygen species (ROS) in a relatively unspecific way, and then reduced (repaired) by designated reductases. While this scheme may work with cysteine, it cannot be ascribed to other residues, such as methionine, whose reaction with ROS is too slow to be biologically relevant. However, methionine is clearly oxidized in vivo and enzymes for its stereoselective reduction are present in all three domains of life. Here, we revisit the chemistry and biology of methionine oxidation, with emphasis on its generation by enzymes from the monooxygenase family. Particular attention is placed on MICALs, a recently discovered family of proteins that harbor an unusual flavin-monooxygenase domain with an NADPH-dependent methionine sulfoxidase activity. Based on structural and kinetic information we provide a rational framework to explain MICAL mechanism, inhibition, and regulation. Methionine residues that are targeted by MICALs are reduced back by methionine sulfoxide reductases, suggesting that reversible methionine oxidation may be a general mechanism analogous to the regulation by phosphorylation by kinases/phosphatases. The identification of new enzymes that catalyze the oxidation of methionine will open a new area of research at the forefront of redox signaling.

Indexed as

Protein Processing, Post-TranslationalAdaptor Proteins, Signal TransducingAnimalsCalponinsCysteineCytoskeletal ProteinsHumansIsoenzymesKineticsLIM Domain ProteinsMethionineMethionine Sulfoxide ReductasesMicrofilament ProteinsMixed Function OxygenasesModels, MolecularNADPAdaptor Proteins, Signal TransducingCalponinsCysteineCytoskeletal ProteinsIsoenzymesLIM Domain ProteinsMethionineMethionine Sulfoxide ReductasesMICAL1 protein, humanMicrofilament ProteinsMixed Function OxygenasesNADPReactive Oxygen SpeciesActinDUF3585MethionineMethionine oxidationMethionine sulfoxideMethionine sulfoxide reductaseMICALMonooxygenaseMultidomain proteinsRedox signalingScaffolding proteins

Identifiers

PMID28229915
PMCPMC5540442
OpenAlexW2588892490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.